A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
An e-Health Intervention for Fear of Progression in Women With Gynecologic or Breast Cancer
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 6 weeks, 6 days
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "ARM I: Patients participate in the Mindful Living Program over 6 weeks consisting of group sessions over 60 minutes each during weeks 1, 3, and 6 and online sessions during weeks 2, 4, and 5."
- "Patients also practice skills related to attention training, detached mindfulness, worry postponement, guided imagery, and other mindfulness practices 10-12 minutes daily for 6 days a week."
- "ARM II: Patients participate in the Navigating Cancer Program over 6 weeks consisting of group sessions over 60 minutes each during weeks 1, 3, and 6 and online sessions during weeks 2, 4, and 5."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated with distress, depression, and increased health care costs, despite this, access to resources to address FOP remain limited. The blended e-health intervention in this trial offers remote group sessions along with online sessions to help patients access the information. Session content incorporates values-based goal setting and skills practices to manage unhelpful beliefs about worry and promote helpful coping behaviors. The sessions may help patients recognize unhelpful thoughts and behaviors which reinforce worry. A blended e-health intervention may be an effective way to improve FOP in women with gynecologic or breast cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Women with stage III or IV GYN (ovarian, endometrial, cervical, vulvar/vaginal) or breast cancer who are at least 2 months from initial diagnosis OR Women with stage I or II endometrial, ovarian, or breast cancer with carcinosarcoma histology OR Women with stage I or II triple negative breast cancer * Score ≥ 34 on the Fear of Progression Short-Form, indicating dysfunctional levels * Age 18 or older; able to read and understand English * Patients can be on active treatment or surveillance. They can be no evidence of disease (NED), recurrent or with progressive disease Exclusion Criteria: * Enrolled in hospice * Ongoing uncontrolled active psychiatric condition that, in the opinion of the investigator, would interfere in the conduct of the study (e.g., mood disorders, psychosis disorders, or substance use), Major depression as assessed by Patient Health Questionnaire-9 (PHQ-9) * Non-English speaking * Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics) * Current participation in a mind-body or mindfulness education program within the past six weeks
Study sites (11)
CA
- City of Hope at Arcadia · Arcadia, CA 91007Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in Arcadia
- City of Hope Medical Center · Duarte, CA 91010Anne Reb · Study contact · 6262184673 · areb@coh.orgAnne Reb · Principal investigatorMore trials in Duarte
- City of Hope at Seacliff · Huntington Beach, CA 92648Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in Huntington Beach
- City of Hope at Irvine Lennar · Irvine, CA 92618Anne Reb · Study contact · 6262184673 · areb@coh.orgAnne Reb · Principal investigatorMore trials in Irvine
- City of Hope Antelope Valley · Lancaster, CA 93534Anne Reb · Study contact · 6262184673 · areb@coh.orgMore trials in Lancaster
- City of Hope at Long Beach Elm · Long Beach, CA 90813Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in Long Beach
- City of Hope at Santa Clarita · Santa Clarita, CA 91355Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in Santa Clarita
- City of Hope at Simi Valley · Simi Valley, CA 93065Anne Reb · Study contact · 6262184673 · areb@coh.orgMore trials in Simi Valley
- City of Hope at South Pasadena · South Pasadena, CA 91030Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in South Pasadena
- City of Hope at Upland · Upland, CA 91786Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in Upland
- City of Hope at West Covina · West Covina, CA 91790Anne Reb, MD · Study contact · 6262184673 · areb@coh.orgMore trials in West Covina